Biomolecular markers in cancer of the tongue

Journal of Oncology

Volumn , Issue , 2009, Pages

  Ferrari, Daris ^a   Codecà, Carla ^a   Fiore, Jessica ^a   Moneghini, Laura ^a   Bosari, Silvano ^a   Foa, Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE IX; CATENIN; CLAUDIN 7; CONNEXIN 31; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FIBRONECTIN; GAP JUNCTION PROTEIN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; OCCLUDIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIMONIDAZOLE; PROTEIN P53; SURVIVIN; TYROSINE KINASE RECEPTOR; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; VIRUS DNA; WNT5A PROTEIN;

ALCOHOL CONSUMPTION; ANGIOGENESIS; APOPTOSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CIGARETTE SMOKING; DISEASE ASSOCIATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUTH CANCER; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; TONGUE CANCER; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

EID: 69249215238     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/412908     Document Type: Review

References (157)

1. Pimenta Amaral T. M., Da Silva F., Carvalho A. L., Pinto C. A. L., Kowalski L. P., Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth Oral Oncology 2004 40 8 780 786
2. Kademani D., Bell R. B., Bagheri S., Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade Journal of Oral and Maxillofacial Surgery 2005 63 11 1599 1605
3. Shantz S. P., Harrison L. B., Forastiere A. A., De Vita T., Hellman S., Rosemberg S. A., Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx Principles and Practice of Oncology 7th
4. Byers R. M., Squamous cell carcinoma of the oral tongue in patients less than thirty years of age American Journal of Surgery 1975 130 4 475 478
5. Jones J. B., Lampe H. B., Cheung H. W., Carcinoma of the tongue in young patients Journal of Otolaryngology 1989 18 3 105 108
6. Llewellyn C. D., Johnson N. W., Warnakulasuriya K. A., Risk factors for squamous cell carcinoma of the oral cavity in young peoplea comprehensive literature review Oral Oncology 2001 37 5 401 418
7. Shiboski C. H., Schmidt B. L., Jordan R. C. K., Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 2044 years Cancer 2005 103 9 1843 1849
8. Annertz K., Anderson H., Birklund A., Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults International Journal of Cancer 2002 101 1 95 99
9. Depue R. H., Rising mortality from cancer of the tongue in young white males The New England Journal of Medicine 1986 315 10 647 468
10. Sarkaria J. N., Harari P. M., Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy Head and Neck 1994 16 2 107 111
11. Byers R. M., Squamous cell carcinoma of the oral tongue in patients less than thirty years of age American Journal of Surgery 1975 130 4 475 478
12. Zhen W., Karnell L. H., Hoffman H. T., Funk G. F., Buatti J. M., Menck H. R., The national cancer data base report on squamous cell carcinoma of the base of tongue Head and Neck 2004 26 8 660 674
13. Mashberg A., Boffetta P., Winkelman R., Garfinkel L., Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. Veterans Cancer 1993 72 4 1369 1375
14. Boffetta P., Mashberg A., Winkelmann R., Garfinkel L., Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx International Journal of Cancer 1992 52 4 530 533
15. Gebhart E., Liehr T., Patterns of genomic imbalances in human solid tumors (Review) International Journal of Oncology 2000 16 2 383 399
16. Brzoska P. M., Levin N. A., Fu K. K., Frequent novel DNA copy number increase in squamous cell head and neck tumors Cancer Research 1995 55 14 3055 3059
17. Bergamo N. A., Rogatto S. R., Poli-Frederico R. C., Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas Cancer Genetics and Cytogenetics 2000 119 1 48 55
18. Singh B., Gogineni S. K., Sacks P. G., Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification Cancer Research 2001 61 11 4506 4513
19. Speicher M. R., Howe C., Crotty P., du Manoir S., Costa J., Ward D. C., Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas Cancer Research 1995 55 5 1010 1013
20. Bockmuhl U., Wolf G., Schmidt S., Genomic alterations associated with malignancy in head and neck cancer Head and Neck 1998 20 2 145 151
21. Weber R. G., Scheer M., Born I. A., Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization American Journal of Pathology 1998 153 1 295 303
22. Singh B., Stoffel A., Gogineni S., Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas American Journal of Pathology 2002 161 2 365 371
23. Redon R., Muller D., Caulee K., Wanherdrick K., Abecassis J., du Manoir S., A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains Cancer Research 2001 61 10 4122 4129
24. Al Moustafa A.-E., Alaoui-Jamali M. A., Batist G., Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells Oncogene 2002 21 17 2634 2640
25. Pattle S. B., Farrell P. J., The role of Epstein-Barr virus in cancer Expert Opinion on Biological Therapy 2006 6 11 1193 1205
26. Young L. S., Murray P. G., Epstein-Barr virus and oncogenesis: from latent genes to tumours Oncogene 2003 22 33 5108 5121
27. Liebowitz D., Nasopharyngeal carcinoma: the Epstein-Barr virus association Seminars in Oncology 1994 21 3 376 381
28. Borza C. M., Hutt-Fletcher L. M., Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus Nature Medicine 2002 8 6 594 599
29. Niedobitek G., Young L. S., Epstein-Barr virus persistence and virus-associated tumours The Lancet 1994 343 8893 333 335
30. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N., Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma The New England Journal of Medicine 1995 333 11 693 698
31. Frangou P., Buettner M., Niedobitek G., Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands Journal of Infectious Diseases 2005 191 2 238 242
32. Herrero R., Castellsagu X., Pawlita M., Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study Journal of the National Cancer Institute 2003 95 23 1772 1783
33. Mork J., Lie A. K., Glattre E., Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck The New England Journal of Medicine 2001 344 15 1125 1131 (Pubitemid 32285233)
34. Gillison M. L., Shah K. V., Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers Current Opinion in Oncology 2001 13 3 183 188
35. Sugerman P. B., Shillitoe E. J., The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship Oral Diseases 1997 3 3 130 147
36. Koskinen W. J., Chen R. W., Leivo I., Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck International Journal of Cancer 2003 107 3 401 406
37. Kantola S., Parikka M., Jokinen K., Prognostic factors in tongue cancerrelative importance of demographic, clinical and histopathological factors British Journal of Cancer 2000 83 5 614 619
38. Dahlgren L., Dahlstrand H., Lindquist D., Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients International Journal of Cancer 2004 112 6 1015 1019
39. Liang X.-H., Lewis J., Foote R., Smith D., Kademani D., Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience Journal of Oral and Maxillofacial Surgery 2008 66 9 1875 1880
40. Brizel D. M., Sibley G. S., Prosnitz L. R., Scher R. L., Dewhirst M. W., Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck International Journal of Radiation Oncology Biology Physics 1997 38 2 285 289
41. Jonathan R. A., Wijffels K. I. E. M., Peeters W., The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON Radiotherapy and Oncology 2006 79 3 288 297
42. Durand R. E., The influence of microenvironmental factors during cancer therapy In Vivo 1994 8 5 691 702
43. Olive P. L., Durand R. E., Drug and radiation resistance in spheroids: cell contact and kinetics Cancer and Metastasis Reviews 1994 13 2 121 138
44. Teicher B. A., Hypoxia and drug resistance Cancer and Metastasis Reviews 1994 13 2 139 168
45. Janssen H. L., Haustermans K. M., Balm A. J., Begg A. C., Hypoxia in head and neck cancer: how much, how important? Head and Neck 2005 27 7 622 638
46. Dachs G. U., Chaplin D. J., Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis Seminars in Radiation Oncology 1998 8 3 208 216
47. Dachs G. U., Tozer G. M., Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation European Journal of Cancer 2000 36 13 1649 1660
48. De Jaeger K., Kavanagh M.-C., Hill R. P., Relationship of hypoxia to metastatic ability in rodent tumours British Journal of Cancer 2001 84 9 1280 1285
49. Beasley N. J. P., Wykoff C. C., Watson P. H., Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density Cancer Research 2001 61 13 5262 5267
50. Hui E. P., Chan A. T. C., Pezzella F., Coexpression of hypoxia-inducible factors 1 and 2, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival Clinical Cancer Research 2002 8 8 2595 2604
51. Roh J.-L., Cho K.-J., Kwon G. Y., The prognostic value of hypoxia markers in T2-staged oral tongue cancer Oral Oncology 2009 45 1 63 68
52. Kennedy A. S., Raleigh J. A., Perez G. M., Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays International Journal of Radiation Oncology Biology Physics 1997 37 4 897 905
53. Varia M. A., Calkins-Adams D. P., Rinker L. H., Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma Gynecologic Oncology 1998 71 2 270 277
54. Wijffels K. I., Kaanders J. H., Rijken P. F., Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas British Journal of Cancer 2000 83 5 674 683
55. Kaanders J. H., Wijffels K. I., Marres H. A. M., Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Research 2002 62 23 7066 7074
56. Veikkola T., Karkkainen M., Claesson-Welsh L., Alitalo K., Regulation of angiogenesis via vascular endothelial growth factor receptors Cancer Research 2000 60 2 203 212 (Pubitemid 30070735)
57. Ferrara N., Davis-Smyth T., The biology of vascular endothelial growth factor Endocrine Reviews 1997 18 1 4 25
58. Kukk E., Lymboussaki A., Taira S., VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development Development 1996 122 12 3829 3837
59. Roskoski R. Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression Critical Reviews in Oncology/Hematology 2007 62 3 179 213
60. Cohen T., Gitay-Goren H., Sharon R., VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells The Journal of Biological Chemistry 1995 270 19 11322 11326
61. Salven P., Lymboussaki A., Heikkila P., Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors American Journal of Pathology 1998 153 1 103 108
62. Jeltsch M., Kaipainen A., Joukov V., Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 1997 276 5317 1423 1425
63. Oh S.-J., Jeltsch M. M., Birkenhager R., VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane Developmental Biology 1997 188 1 96 109
64. Kaipainen A., Korhonen J., Mustonen T., Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development Proceedings of the National Academy of Sciences of the United States of America 1995 92 8 3566 3570
65. Kukk E., Lymboussaki A., Taira S., VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development Development 1996 122 12 3829 3837
66. Benefield J., Petruzzelli G. J., Fowler S., Taitz A., Kalkanis J., Young M. R. I., Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas Invasion and Metastasis 1996 16 6 291 301
67. O-Charoenrat P., Rhys-Evans P., Eccles S. A., Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis Cancer 2001 92 3 556 568
68. Siriwardena B. S., Kudo Y., Ogawa I., Udagama M. N., Tilakaratne W. M., Takata T., VEGF-C is associated with lymphatic status and invasion in oral cancer Journal of Clinical Pathology 2008 61 1 103 108
69. Kishimoto K., Sasaki A., Yoshihama Y., Mese H., Tsukamoto G., Matsumura T., Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma Oral Oncology 2003 39 4 391 396
70. Kim S. H., Cho N. H., Kim K., Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression Journal of Surgical Oncology 2006 93 4 330 337
71. Faustino S. E. S., Oliveira D. T., Nonogaki S., Landman G., Carvalho A. L., Kowalski L. P., Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma International Journal of Oral and Maxillofacial Surgery 2008 37 4 372 378
72. Cho J. H., Kim H.-S., Park C.-S., Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF) Oral Oncology 2007 43 3 272 277
73. Sheng S., The promise and challenge toward the clinical application of maspin in cancer Frontiers in Bioscience 2004 9 2733 2745
74. Zhang M., Volpert O., Shi Y. H., Bouck N., Maspin is an angiogenesis inhibitor Nature Medicine 2000 6 2 196 199
75. Le Querrec A., Duval D., Tobelem G., Tumour angiogenesis Baillieres Clinical Haematology 1993 6 3 711 730
76. Ellerbroek S. M., Halbleib J. M., Benavidez M., Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association Cancer Research 2001 61 5 1855 1861
77. Agarwal R., DSouza T., Morin P. J., Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity Cancer Research 2005 65 16 7378 7385
78. Hayashida Y., Honda K., Idogawa M., E-cadherin regulates the association between -catenin and actinin-4 Cancer Research 2005 65 19 8836 8845
79. Nei H., Saito T., Tobioka H., Itoh E., Mori M., Kudo R., Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation Cancer 1996 78 3 461 470
80. Bazarbachi A., Abou Merhi R., Gessain A., Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism Cancer Research 2004 64 6 2039 2046
81. Gonzalez-Mariscal L., Betanzos A., Nava P., Jaramillo B. E., Tight junction proteins Progress in Biophysics and Molecular Biology 2003 81 1 1 44
82. Mitic L. L., Anderson J. M., Molecular architecture of tight junctions Annual Review of Physiology 1998 60 121 142
83. Mullin J. M., Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis Journal of Experimental Zoology 1997 279 5 484 489
84. Soini Y., Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours Histopathology 2005 46 5 551 560
85. Oku N., Sasabe E., Ueta E., Yamamoto T., Osaki T., Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1 Cancer Research 2006 66 10 5251 5257
86. Bello I. O., Vilen S.-T., Niinimaa A., Kantola S., Soini Y., Salo T., Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue Human Pathology 2008 39 8 1212 1220
87. Popescu N. C., King C. R., Kraus M. H., Localization of the human ErbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32 Genomics 1989 4 3 362 366
88. Olayioye M. A., Neve R. M., Lane H. A., Hynes N. E., The ErbB signaling network: receptor heterodimerization in development and cancer The EMBO Journal 2000 19 13 3159 3167
89. Xia W., Lau Y.-K., Zhang H.-Z., Strong correlation between c-ErbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma Clinical Cancer Research 1997 3 1 3 9
90. Xia W., Lau Y.-K., Zhang H.-Z., Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members Clinical Cancer Research 1999 5 12 4164 4174
91. Werkmeister R., Brandt B., Joos U., Clinical relevance of ErbB-1 and -2 oncogenes in oral carcinomas Oral Oncology 2000 36 1 100 105
92. Bei R., Pompa G., Vitolo D., Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma Journal of Pathology 2001 195 3 343 348
93. Khan A. J., King B. L., Smith B. D., Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma Clinical Cancer Research 2002 8 2 540 548
94. Khademi B., Shirazi F. M., Vasei M., The expression of p53, c-ErbB-1 and c-ErbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors Cancer Letters 2002 184 2 223 230
95. Innocenzi D., Alo P. L., Balzani A., Fatty acid synthase expression in melanoma Journal of Cutaneous Pathology 2003 30 1 23 28
96. Takahiro T., Shinichi K., Toshimitsu S., Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas Clinical Cancer Research 2003 9 6 2204 2212
97. Alo P. L., Visca P., Framarino M. L., Immunohistochemical study of fatty acid synthase in ovarian neoplasms Oncology Reports 2000 7 6 1383 1388
98. Kusakabe T., Nashimoto A., Honma K., Suzuki T., Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach Histopathology 2002 40 1 71 79
99. Silva S. D., Agostini M., Nishimoto I. N., Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study Oral Oncology 2004 40 7 688 696
100. Agostini M., Silva S. D., Zecchin K. G., Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells Oral Oncology 2004 40 7 728 735
101. Jayakumar A., Tai M.-H., Huang W.-Y., Human fatty acid synthase: properties and molecular cloning Proceedings of the National Academy of Sciences of the United States of America 1995 92 19 8695 8699
102. Menendez J. A., Lupu R., Colomer R., Targeting fatty acid synthase: potential for therapeutic intervention in Her-2/neu-overexpressing breast cancer Drug News and Perspectives 2005 18 6 375 385
103. Silva S. D., Perez D. E., Alves F. A., ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes Oral Oncology 2008 44 5 484 490
104. Silva S. D., Perez D. E., Nishimoto I. N., Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings Oral Diseases 2008 14 4 376 382
105. Angiero F., Sordo R. D., Dessy E., Comparative analysis of c-ErbB-2 (HER-2/neu) in squamous cell carcinoma of the tongue: does over-expression exist? And what is its correlation with traditional diagnostic parameters? Journal of Oral Pathology and Medicine 2008 37 3 145 150
106. Chang F., Syrjanen S., Syrjanen K., Implications of the p53 tumor-suppressor gene in clinical oncology Journal of Clinical Oncology 1995 13 4 1009 1022
107. Lowe S. W., Bodis S., McClatchey A., p53 status and the efficacy of cancer therapy in vivo Science 1994 266 5186 807 810
108. Lowe S. W., Ruley H. E., Jacks T., Housman D. E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 1993 74 6 957 967
109. Suzuki H., Takahashi T., Kuroishi T., p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking Cancer Research 1992 52 3 734 736
110. Wang X., Christiani D. C., Wiencke J. K., Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure Cancer Epidemiology Biomarkers and Prevention 1995 4 5 543 548
111. Field J. K., Spandidos D. A., Malliri A., Gosney J. R., Yiagnisis M., Stell P. M., Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck British Journal of Cancer 1991 64 3 573 577
112. Matthews J. B., Scully C., Jovanovic A., Van der Waal I., Yeudall W. A., Prime S. S., Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas European Journal of Cancer Part B 1993 29 4 285 289
113. Atula S., Kurvinen K., Grinman R., Syrjken S., SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer European Journal of Cancer Part B 1996 32 4 222 229
114. Sameshima Y., Matsuno Y., Hirohashi S., Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma Oncogene 1992 7 3 451 457
115. Pohl J., Goldfinger N., Radler-Pohl A., Rotter V., Schirrmacher V., p53 increases experimental metastatic capacity of murine carcinoma cells Molecular and Cellular Biology 1988 8 5 2078 2081
116. Vogelstein B., A deadly inheritance Nature 1990 348 6303 681 682
117. Vora H. H., Trivedi T. I., Shukla S. N., Shah N. G., Goswami J. V., Shah P. M., p53 expression in leukoplakia and carcinoma of the tongue International Journal of Biological Markers 2006 21 2 74 80
118. Nagler R. M., Kerner H., Laufer D., Ben-Eliezer S., Minkov I., Ben-Itzhak O., Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-ErbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study Cancer Letters 2002 186 2 137 150
119. Keum K. C., Chung E. J., Koom W. S., Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer Otolaryngology: Head and Neck Surgery 2006 135 6 858 864
120. Senger D. R., Wirth D. F., Hynes R. O., Transformed mammalian cells secrete specific proteins and phosphoproteins Cell 1979 16 4 885 893
121. Liaw L., Skinner M. P., Raines E. W., The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of (v) 3 in smooth muscle cell migration to osteopontin in vitro Journal of Clinical Investigation 1995 95 2 713 724
122. Wai P. Y., Kuo P. C., The role of osteopontin in tumor metastasis Journal of Surgical Research 2004 121 2 228 241
123. Singhai H., Bautista D. S., Tonkin K. S., Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival Clinical Cancer Research 1997 3 4 605 611
124. Ue T., Yokozaki H., Kitadai Y., Co-expression of osteopontin and CD44v9 in gastric cancer International Journal of Cancer 1998 79 2 127 132
125. Kim J.-H., Skates S. J., Uede T., Osteopontin as a potential diagnostic biomarker for ovarian cancer Journal of the American Medical Association 2002 287 13 1671 1679
126. Agrawal D., Chen T., Irby R., Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling Journal of the National Cancer Institute 2002 94 7 513 521
127. Oates A. J., Barraclough R., Rudland P. S., The role of osteopontin in tumorigenesis and metastasis Invasion and Metastasis 1997 17 1 1 15
128. Weber G. F., The metastasis gene osteopontin: a candidate target for cancer therapy Biochimica et Biophysica Acta 2001 1552 2 61 85
129. Tuck A. B., Arsenault D. M., OMalley F. P., Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells Oncogene 1999 18 29 4237 4246
130. Matsuzaki H., Shima K., Muramatsu T., Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue Journal of Oral Pathology and Medicine 2007 36 1 30 34
131. Chien C.-Y., Su C.-Y., Chuang H.-C., Clinical significance of osteopontin expression in T1 and T2 tongue cancers Head and Neck 2008 30 6 776 781
132. Ambrosini G., Adida C., Altieri D. C., A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nature Medicine 1997 3 8 917 921
133. Deveraux Q. L., Reed J. C., IAP family proteinssuppressors of apoptosis Genes and Development 1999 13 3 239 252
134. Thornberry N. A., Caspases: a decade of death research Cell Death and Differentiation 1999 6 11 1023 1027
135. Dohi T., Okada K., Xia F., An IAP-IAP complex inhibits apoptosis The Journal of Biological Chemistry 2004 279 33 34087 34090
136. Lo Muzio L., Farina A., Rubini C., Survivin as prognostic factor in squamous cell carcinoma of the oral cavity Cancer Letters 2005 225 1 27 33 (Pubitemid 40732765)
137. Lin C.-Y., Hung H.-C., Kuo R.-C., Chiang C.-P., Kuo M. Y.-P., Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan Oral Oncology 2005 41 6 645 654
138. Freier K., Pungs S., Sticht C., High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy International Journal of Cancer 2007 120 4 942 946
139. Carpenter G., Cohen S., Epidermal growth factor The Journal of Biological Chemistry 1990 265 14 7709 7712
140. Hardisson D., Molecular pathogenesis of head and neck squamous cell carcinoma European Archives of Oto-Rhino-Laryngology 2003 260 9 502 508
141. Kalyankrishna S., Grandis J. R., Epidermal growth factor receptor biology in head and neck cancer Journal of Clinical Oncology 2006 24 17 2666 2672
142. Grandis J. R., Tweardy D. J., Elevated levels of transforming growth factor and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer Cancer Research 1993 53 15 3579 3584
143. Pivot X., Magn N., Guardiola E., Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer Oral Oncology 2005 41 3 320 327
144. Hitt R., Ciruelos E., Amador M. L., Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy European Journal of Cancer 2005 41 3 453 460
145. Ang K. K., Berkey B. A., Tu X., Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Research 2002 62 24 7350 7356
146. Liang K., Ang K. K., Milas L., Hunter N., Fan Z., The epidermal growth factor receptor mediates radioresistance International Journal of Radiation Oncology Biology Physics 2003 57 1 246 254
147. Katoh K., Nakanishi Y., Akimoto S., Correlation between laminin-5 2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue Oncology 2002 62 4 318 326 (Pubitemid 34914101)
148. Santini J., Formento J.-L., Francoual M., Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas Head and Neck 1991 13 2 132 139
149. Grandis J. R., Melhem M. F., Barnes E. L., Tweardy D. J., Quantitative immunohistochemical analysis of transforming growth factor- and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck Cancer 1996 78 6 1284 1292
150. Eberhard D. A., Johnson B. E., Amler L. C., Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib Journal of Clinical Oncology 2005 23 25 5900 5909
151. Wirth L. J., Haddad R. I., Lindeman N. I., Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck Journal of Clinical Oncology 2005 23 28 6976 6981
152. Cohen E. E. W., Rosen F., Stadler W. M., Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck Journal of Clinical Oncology 2003 21 10 1980 1987
153. Lee J. W., Soung Y. H., Kim S. Y., Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck Clinical Cancer Research 2005 11 8 2879 2882
154. Mahmoud A. L., Sheikh A., Gunduz G. M., Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma Cancer Science 2008 98 8 1589 1594
155. Lemos-Gonzlez Y., Pez de la Cadena M., Rodrguez-Berrocal F. J., Rodrguez-Pieiro A. M., Pallas E., Valverde D., Absence of activating mutations in the EGFR kinase domain in spanish head and neck cancer patients Tumor Biology 2007 28 5 273 279
156. Loeffler-Ragg J., Witsch-Baumgartner M., Tzankov A., Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma European Journal of Cancer 2006 42 1 109 111
157. Ulanovski D., Stern Y., Roizman P., Shpitzer T., Popovtzer A., Feinmesser R., Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue Oral Oncology 2004 40 5 532 537